Related Experiment Videos
Summary
Maternal hyaluronidase activity is less reliable for assessing fetoplacental well-being than HPL or estriol. However, altered hyaluronidase levels may indicate fetal death or placental dysfunction during pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Biochemistry
- Maternal-Fetal Medicine
Background:
- Assessing fetoplacental well-being is crucial for managing high-risk pregnancies.
- Human placental lactogen (HPL) and pregnancy estriol are established biochemical markers.
- Hyaluronidase activity in maternal serum has been explored as a potential marker.
Purpose of the Study:
- To compare the efficacy of maternal serum hyaluronidase activity with HPL and urinary estriol in indicating fetoplacental well-being.
- To investigate the association between hyaluronidase activity and pregnancy complications, including fetal death and fetoplacental dysfunction.
Main Methods:
- Prospective follow-up of 291 pregnant women.
- Assay of maternal serum for hyaluronidase activity and HPL.
- Assay of 24-hour urine for estriol output.
Main Results:
- Hyaluronidase activity was a less accurate indicator of fetoplacental well-being compared to HPL and estriol.
- Mean hyaluronidase levels differed between normal and complicated pregnancies.
- Increased hyaluronidase activity correlated with fetal death.
- Decreased hyaluronidase activity correlated with fetoplacental dysfunction.
Conclusions:
- Maternal serum hyaluronidase activity is not as effective as HPL or estriol for routine assessment of fetoplacental well-being.
- Elevated hyaluronidase activity may suggest fetal demise, while decreased activity could indicate fetoplacental dysfunction, warranting further investigation.